mesalamine and folic acid

mesalamine has been researched along with folic acid in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19901 (7.69)18.7374
1990's1 (7.69)18.2507
2000's2 (15.38)29.6817
2010's7 (53.85)24.3611
2020's2 (15.38)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Banatwala, N1
Abdo, KM; Hart, RW; Iatropoulos, MJ; Kari, FW; Williams, GM1
Croog, VJ; Itzkowitz, SH; Ullman, TA1
Burakoff, R; Levine, JS1
Pai, C; Sharif, O; Silverman, AL; Tang, J1
Hibi, T; Yajima, T1
Ardizzone, S; Danese, S; Gasche, C; Hernández, V; Kariv, R; Marti-Gallostra, M; Myrelid, P; Sebastian, S; Spinelli, A; Toruner, M; Tsianos, E; van der Meulen-de Jong, AE; Yuksel, ES1
Han, SH; Lee, J1
Brusač, E; Jeličić, ML; Klarić, DA; Mornar, A; Nigović, B; Turk, N1
Bai, X; Chen, L; Lin, Y; Liu, Z; Luo, Z; Yang, R; Zhang, Z; Zhong, Z; Zhou, M1

Reviews

6 review(s) available for mesalamine and folic acid

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Salazopyrin and its newer analogues in the treatment of inflammatory bowel disease.
    JPMA. The Journal of the Pakistan Medical Association, 1985, Volume: 35, Issue:3

    Topics: Aminosalicylic Acids; Colitis, Ulcerative; Crohn Disease; Double-Blind Method; Drug Combinations; Drug Interactions; Enema; Female; Folic Acid; Glucosamine; Humans; Mesalamine; Pregnancy; Sulfapyridine; Sulfasalazine

1985
Chemoprevention of colorectal cancer in ulcerative colitis.
    International journal of colorectal disease, 2003, Volume: 18, Issue:5

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Calcium, Dietary; Chemoprevention; Cholagogues and Choleretics; Colitis, Ulcerative; Colorectal Neoplasms; Folic Acid; Hematinics; Humans; Mesalamine; Ursodeoxycholic Acid

2003
Chemoprophylaxis of colorectal cancer in inflammatory bowel disease: current concepts.
    Inflammatory bowel diseases, 2007, Volume: 13, Issue:10

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cholagogues and Choleretics; Colorectal Neoplasms; Folic Acid; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Mesalamine; Treatment Outcome; Ursodeoxycholic Acid; Vitamin B Complex

2007
Colorectal cancer in inflammatory bowel disease: results of the 3rd ECCO pathogenesis scientific workshop (I).
    Journal of Crohn's & colitis, 2014, Volume: 8, Issue:1

    Topics: Age of Onset; Anticarcinogenic Agents; Cholangitis, Sclerosing; Colitis, Ulcerative; Colorectal Neoplasms; Congresses as Topic; Crohn Disease; Folic Acid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunologic Factors; Mesalamine; Risk Factors; Survival Rate; Time Factors; Ursodeoxycholic Acid

2014
[Chemoprevention of colorectal cancer in inflammatory bowel disease].
    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2014, Jan-25, Volume: 63, Issue:1

    Topics: Anti-Inflammatory Agents; Chemoprevention; Colorectal Neoplasms; Folic Acid; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mesalamine; Ursodeoxycholic Acid

2014

Other Studies

7 other study(ies) available for mesalamine and folic acid

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
Mechanistic studies on genotoxicity and carcinogenicity of salicylazosulfapyridine an anti-inflammatory medicine.
    Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie, 1997, Volume: 49, Issue:1-2

    Topics: Aminosalicylic Acids; Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Bone Marrow; Carcinogenicity Tests; DNA Adducts; Female; Folic Acid; Liver; Male; Mesalamine; Mice; Micronuclei, Chromosome-Defective; Mutagenicity Tests; Rats; Rats, Sprague-Dawley; Risk Assessment; Sulfapyridine; Sulfasalazine; Urinary Bladder

1997
Mesalamine protects against colorectal cancer in inflammatory bowel disease.
    Digestive diseases and sciences, 2010, Volume: 55, Issue:6

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Case-Control Studies; Chi-Square Distribution; Colorectal Neoplasms; Disease Progression; Female; Folic Acid; Gastrointestinal Agents; Humans; Inflammatory Bowel Diseases; Logistic Models; Male; Mesalamine; Middle Aged; Odds Ratio; Retrospective Studies; Risk Assessment; Risk Factors; ROC Curve; Treatment Outcome; Young Adult

2010
[Chemoprevention of colorectal cancer associated with IBD].
    Nihon rinsho. Japanese journal of clinical medicine, 2012, Volume: 70 Suppl 1

    Topics: Azathioprine; Colorectal Neoplasms; Crohn Disease; Folic Acid; Humans; Inflammatory Bowel Diseases; Mercaptopurine; Mesalamine

2012
A chromatographic approach to development of 5-aminosalicylate/folic acid fixed-dose combinations for treatment of Crohn's disease and ulcerative colitis.
    Scientific reports, 2020, 11-30, Volume: 10, Issue:1

    Topics: Chromatography; Colitis, Ulcerative; Crohn Disease; Drug Combinations; Folic Acid; Humans; Inflammatory Bowel Diseases; Mesalamine; Sulfasalazine

2020
A novel dual-prodrug carried by cyclodextrin inclusion complex for the targeting treatment of colon cancer.
    Journal of nanobiotechnology, 2021, Oct-19, Volume: 19, Issue:1

    Topics: Animals; Antineoplastic Agents; Butyric Acid; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Cyclodextrins; Drug Delivery Systems; Folic Acid; Male; Mesalamine; Mice; Mice, Nude; Prodrugs

2021